SOD2 and metastatic malignant neoplasm: Indeed, increased SOD2 expression parallels with glycolytic metabolism, especially in aggressive metastatic cancers, causing the activation of 5′ adenosine monophosphate-activated kinase (AMPK), which further stimulates glycolysis.